Bacteriophage-based approach for managing shigella infections

Ended Cooperative Agreement Awarded Last action

Award ID
U01AI148054
Recipient
Awarding agency
Obligated
$13,286,821

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $11,847,093.00 Federal
  • $1,439,728.00 Non-federal
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,162,758 $0
Amendment $1,162,758 $0
Amendment $1,172,622 $0
Amendment $1,172,622 $0
Amendment $1,172,622 $0
Amendment $1,171,611 $0
Amendment $1,439,728 $0
Amendment $1,439,728 $1,439,728
Amendment $348,233 $0
Original award $1,604,411 $0
Show all 13

Quick answers

Who received award U01AI148054?

U01AI148054 was awarded to Intralytix Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 5, 2020.

How much is award U01AI148054 worth?

$13,286,821 has been obligated on U01AI148054: $11,847,093 in federal funding and $1,439,728 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award